Adjuvant treatment and survival in obese women with endometrial cancer: An international collaborative study

American Journal of Obstetrics and Gynecology

Volumn 198, Issue 1, 2008, Pages 89.e1-89.e8

  Martra, Francesca ^a   Kunos, Charles ^b   Gibbons, Heidi ^b   Zola, Paolo ^a   Galletto, Luciano ^a   DeBernardo, Robert ^b   von Gruenigen, Vivian ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

endometrial cancer; lymphadenectomy; obesity; radiation

Indexed keywords

ADULT; ARTICLE; BODY MASS; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HISTOPATHOLOGY; HUMAN; KAPLAN MEIER METHOD; LOGISTIC REGRESSION ANALYSIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RADIATION RELATED PHENOMENA; RETROSPECTIVE STUDY; SCORING SYSTEM; SKIN TOXICITY; WOMEN'S HEALTH;

EID: 37349075407     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.06.023     Document Type: Article

References (23)

1. Parazzini F., La Vecchia C., Bocciolone L., and Franceschi S. The epidemiology of endometrial cancer. Gynecol Oncol 41 (1991) 1-16
2. Kaaks R., Lukanova A., and Kurzer M.S. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol, Biomarkers Prev 11 (2002) 1531-1543
3. Everett E., Tamimi H., Greer B., et al. The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol Oncol 90 (2003) 150-157
4. Pavelka J.C., Ben-Shachar I., Fowler J.M., et al. Morbid obesity and endometrial cancer: surgical, clinical, and pathologic outcomes in surgically managed patients. Gynecol Oncol 95 (2004) 588-592
5. Eifel P.J., Jhingran A., Bodurka D.C., Levenback C., and Thames H. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol 20 (2002) 3651-3657
6. von Gruenigen V.E., Tian C., Frasure H., Waggoner S., Keys H., and Barakat R.R. Treatment effects, disease recurrence, and survival as related to obesity in women with early endometrial carcinoma: a Gynecologic Oncology Group study. Cancer 107 (2006) 2786-2791
7. Goudge C., Bernhard S., Cloven N.G., and Morris P. The impact of complete surgical staging on adjuvant treatment decisions in endometrial cancer. Gynecol Oncol 93 (2004) 536-539
8. Roland P.Y., Kelly F.J., Kulwicki C.Y., Blitzer P., Curcio M., and Orr Jr. J.W. The benefits of a gynecologic oncologist: a pattern of care study for endometrial cancer treatment. Gynecol Oncol 93 (2004) 125-130
9. Garrow J., and Webster J. Quetelet's index (W/H2) as a measure of fatness. Int J Obes 9 (1985) 147-153
10. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults 158 (1998) 1855-1867
11. Keys H.M., Roberts J.A., Brunetto V.L., et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92 (2004) 744-751
12. Creutzberg C.L., van Putten W.L., Koper P.C., et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial: PORTEC Study Group: post operative radiation therapy in endometrial carcinoma. Lancet 355 (2000) 1404-1411
13. Grodin J.M., Siiteri P.K., and MacDonald P.C. Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab 36 (1973) 207-214
14. Edman C.D., and MacDonald P.C. Effect of obesity on conversion of plasma androstenedione to estrone in ovulatory and anovulatory young women. Am J Obstet Gynecol 130 (1978) 456-461
15. Meseguer A., Puche C., and Cabero A. Sex steroid biosynthesis in white adipose tissue. Horm Metab Res 34 (2002) 731-736
16. Creasman W.T., Morrow C.P., Bundy B.N., Homesley H.D., Graham J.E., and Heller P.B. Surgical pathologic spread patterns of endometrial cancer. a Gynecologic Oncology Group study. Cancer 60 (1987) 2035-2041
17. Morrow C.P., Bundy B.N., Kurman R.J., et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40 (1991) 55-65
18. Lurain J.R., Rice B.L., Rademaker A.W., Poggensee L.E., Schink J.C., and Miller D.S. Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 78 (1991) 63-69
19. Lee C.M., Szabo A., Shrieve D.C., Macdonald O.K., and Gaffney D.K. Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. JAMA 295 (2006) 389-397
20. Small W., and Lurain J.R. Current management of endometrial cancer: surgical staging and postoperative radiotherapy. Am J Oncol Rev 5 (2006) 165-174
21. Kilgore L.C., Partridge E.E., Alvarez R.D., et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic nodal sampling. Gynecol Oncol 56 (1995) 29-33
22. Mariani A., Webb M.J., Galli L., and Podratz K.C. Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol Oncol 76 (2000) 348-356
23. Cragun J.M., Havrilesky L.J., Calingaert B., et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 23 (2005) 3668-3675